Deuterium Capital Management’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,541
Closed -$129K 51
2023
Q3
$129K Sell
50,541
-250,546
-83% -$725K 0.31% 48
2023
Q2
$957K Buy
301,087
+50,541
+20% +$149K 1.24% 18
2023
Q1
$707K Buy
250,546
+106,380
+74% +$278K 1.11% 26
2022
Q4
$392K Buy
+144,166
New +$420K 1.04% 26

Other funds holding ABEV

Deuterium Capital Management's ABEV Position: Q4 2023 in Review

Deuterium Capital Management sold out of Ambev (ABEV) in Q4 2023, closing a stake of 50,541 shares — an estimated $129K sold.

Deuterium Capital Management first reported a position in ABEV in Q4 2022 and held it in 4 quarters. The position peaked at $957K in Q2 2023. 345 funds tracked by Wall St. Rank hold ABEV as of Q4 2023.

  • Deuterium Capital Management reported no remaining Ambev position as of Q4 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 50,541 Ambev shares in Q4 2023, an estimated $129K.
  • Deuterium Capital Management first reported a position in Ambev in Q4 2022 and held it in 4 quarters.
  • Deuterium Capital Management's Ambev position peaked at $957K in Q2 2023.
  • 345 funds tracked by Wall St. Rank held Ambev as of Q4 2023.

Based on Deuterium Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.